Enodia Therapeutics
PrivateLast Round
Seed
Jan 8, 2026
Total Funding Raised
$25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Enodia Therapeutics is a biotechnology company that develops small-molecule therapies that enable the degradation of disease-driving proteins at the point of synthesis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enodia Therapeutics Comparables
Compare Enodia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gate Bioscience | 79% | |
| Initial Therapeutics | 73% | |
| Sibylla Biotech | 71% |
Enodia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 8, 2026 |
Enodia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investsud | Seed |
| Elaia Partners | Seed |
| Wallonie Entreprendre | Seed |
| Pfizer Ventures | Seed |
| Mission BioCapital | Seed |
| Institut Pasteur | Seed |
| Sambrinvest | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 30, 2026
Grew 27% QoQ from 11 to 14 employees.
- Jul 18, 2026
Grew 50% QoQ, from 8 to 12 employees.
Enodia Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Enodia Therapeutics's valuation, stock price, and market status.
Is Enodia Therapeutics a public or private company?
Enodia Therapeutics is a private company.
What is the current stock price of Enodia Therapeutics?
Enodia Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Enodia Therapeutics worth (valuation)?
Valuation information for Enodia Therapeutics is not publicly available.
Can I buy Enodia Therapeutics stock?
Enodia Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Enodia Therapeutics's last funding round?
Enodia Therapeutics's most recent funding round was Seed on January 8, 2026.
Who are the main investors in Enodia Therapeutics?
Key investors in Enodia Therapeutics include Elaia Partners, Bpifrance, Pfizer Ventures, Bpifrance, Pfizer Ventures.
Will Enodia Therapeutics IPO soon?
No public IPO plans have been announced for Enodia Therapeutics.
How can I track Enodia Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Enodia Therapeutics's secondary market activity and sign up for updates.